Architecting Enterprise AI for Generative and Agentic Systems – with Ranjan Sinha of IBM
Maintaining legacy IT platforms has become a massive financial and operational drag. Research from Pegasystems Inc., in partnership with research firm…


Read the Emerj team’s latest coverage on AI use-cases and trends in banking.
Maintaining legacy IT platforms has become a massive financial and operational drag. Research from Pegasystems Inc., in partnership with research firm…

This interview analysis is sponsored by Deloitte and was written, edited, and published in alignment with our Emerj sponsored content guidelines.…

Across regulated and asset-intensive industries, AI adoption is shaped by factors beyond technical feasibility. Organizations now seek to deploy AI systems…

Bristol Myers Squibb is a global biopharmaceutical leader dedicated to delivering innovative medicines across oncology, hematology, immunology, cardiovascular disease, and neuroscience.…

This article is sponsored by NLP Logix and was written, edited, and published in alignment with our Emerj sponsored content guidelines.…

This interview analysis is sponsored by AnswerRocket and was written, edited, and published in alignment with our Emerj sponsored content guidelines.…

Clinical trials comprise the most significant portion of drug development costs. In some cases, drug R&D costs can approach as high…
